By continuing to use this site you consent to the use of cookies on your device. Find out more about our cookie policy and the types of cookies we use by clicking here.

Franklin Biotechnology Discv A Acc $

Performance History30/11/2016
Growth of 1,000 (EUR)
Franklin Biotechnology Discv A Acc $
Fund24.957.253.416.9-13.1
+/-Cat0.26.04.9-2.50.4
+/-Idx-16.9-3.34.5-3.0-3.6
 
Key Stats
NAV
02/12/2016
 USD 27.69
Day Change 0.19%
Morningstar Category™ Sector Equity Biotechnology
ISIN LU0109394709
Fund Size (Mil)
31/10/2016
 USD 2034.38
Share Class Size (Mil)
31/10/2016
 USD 1689.73
Max Initial Charge 5.75%
Ongoing Charge
08/06/2016
  1.81%
Investment Objective: Franklin Biotechnology Discv A Acc $
The Fund’s investment objective is capital appreciation. The Fund invests principally in equity securities of biotechnology companies and discovery research firms (including small to mid-sized companies) located in the US and other countries, and to a lesser extent in debt securities of any type of issuers worldwide.
Returns
Trailing Returns02/12/2016
YTD-14.37
3 Years Annualised15.88
5 Years Annualised25.78
10 Years Annualised14.67
12 Month Yield 0.00
Management
Manager Name
Start Date
Evan McCulloch
01/11/2000
Christopher Lee
15/09/2015
Click here to see others
Inception Date
03/04/2000
Advertisement
Benchmarks
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology PR USDMSCI World/Biotechnology NR USD
Portfolio Profile for  Franklin Biotechnology Discv A Acc $31/07/2016
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks97.370.0097.37
Bonds0.000.000.00
Cash1.120.001.12
Other1.500.001.50
Top 5 Regions%
United States96.93
Canada0.93
United Kingdom0.84
Middle East0.83
Eurozone0.47
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Celgene CorpHealthcareHealthcare9.94
Biogen IncHealthcareHealthcare7.91
Gilead Sciences IncHealthcareHealthcare6.89
Amgen IncHealthcareHealthcare6.17
Incyte CorpHealthcareHealthcare4.29
Franklin Biotechnology Discv A Acc $